Posts By: Mae Bennett

Bradley G. Somer, MD, associate professor of hematology/oncology, head of strategic expansion/development, University of Tennessee West Cancer Center, discusses the potential for immunotherapy combinations in patients with metastatic renal cell carcinoma (mRCC). In the CheckMate-214 study, the combination of nivolumab (Opdivo) and ipilimumab (Yervoy) showed a clear survival advantage over the frontline standard-of-care sunitinib (Sutent)… Read more »

West Cancer Center is proud to introduce Dr. David B. Robins, MD our newest Pathologist to join our team. Dr. Robins completed his medical school training at University of Witwatersrand, Johannesburg, South Africa, in 1982. He then did his residency in anatomic pathology and a surgical pathology fellowship (with added emphasis in gynecologic pathology) at… Read more »

Daniel Vaena, MD, medical oncologist and hematologist, West Cancer Center, discusses the importance of risk stratification in prostate cancer. It is important to remember that patients need to be carefully selected for treatment based on risk stratification, says Vaena. There are many new therapeutic agents available to patients with metastatic disease and castration-naïve disease; however,… Read more »

As we move into holiday season, our Integrative Oncology department is launching a video ministry series for patients, caregivers, and staff members! Be on the look out each Wednesday for a video message from our Spiritual Council, including our very own Chaplain, Makeba Garrison! Our Council will be addressing things like grief, gratitude, meditation, and… Read more »

September is light blue ribbon month, also known as Prostate Cancer Awareness month It’s a time to recognize a disease that will cause the death of an estimated 30,000 men this year, one that affects one in nine men here in the U.S. African-American men are impacted in even greater numbers. One in six African-American men will develop… Read more »

West Cancer Center’s Executive Director, Lee Schwartzberg, MD, FACP presented key findings from a phase III study at the Multinational Association of Supportive Care in Cancer (MASCC) Annual meeting held in Vienna, Austria, June 28-30. He was lead investigator for the study titled “Eflapegrastim is Safe and Effective in Reducing Severe Neutropenia in Patients Receiving… Read more »

Just what the doctor ordered! Every great city demands great doctors. Although adequate funding and state-of-the-art facilities play an important role in developing viable medical care, it is the ingenuity and dedication of great medical minds that truly raise the bar. Our West Cancer Center doctors have been recognized for their dedication to medical research… Read more »

We are very proud of the recent article by W. Clay Jackson, MD, DipTh, one of our Palliative Care Physicians, in the Pain Practitioner Summer 2018 issue. A Treatment Choice – a patient’s perspective.

Check out the recent Local Memphis Top Story interview with Dr. Pallera on newly released findings about treatment for early stage breast cancer!   For the full TV interview, please Click Here.   “This study, which never would have happened without federal funding for cancer research, will transform care immediately, and for the better. These data… Read more »